4 Recruiting Pancreatic Ductal Adenocarcinoma Clinical Trials in New York
Explore active pancreatic ductal adenocarcinoma research studies enrolling across New York. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Pancreatic Ductal Adenocarcinoma Studies in New York
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
📍 Roswell Park Comprehensive Cancer Center — Buffalo, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
📍 Northwell Health R.J. Zuckerberg Cancer Center — Lake Success, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
📍 Imbert Cancer Center — Bay Shore, New York
View Study & Checklist ➔